News and Views
Read More
Hypophosphatemia Following IV Iron Administration: An Emerging Safety Concern
Used since the early 20th century to treat iron-deficiency anemia for a wide range of patient populations and therapeutic indications (e.g., oncology conditions, nephrology, women’s health), IV iron formulations have become safer over time. However, emerging data have identified post-infusion hypophosphatemia as a safety concern.